Protocol for the Development of a Consensus Practice Guideline to Address Clinical and Regulatory Barriers to Buprenorphine Dispensing in Community Pharmacy DOI Open Access
Tyler J. Varisco

Published: April 12, 2023

Less than half of community pharmacies in the United States actively stock buprenorphine products indicated for treatment opioid use disorder. This lack access to is a significant barrier care persons with To address this issue, protocol outlines comprehensive approach develop practice guideline aimed at improving safe and effective disorder pharmacies. The development process will proceed three phases, following technique closely aligned Institute Medicine's guidance on development. first phase involve conducting qualitative interviews pharmacists states identify their beliefs toward dispensing. In second phase, modified Delphi panel be used consensus recommendations, which followed by public comment period external expert review recommendations led National Association Boards Pharmacy. Finally, third national, mixed media dissemination campaign Community Pharmacists (NCPA) convey practicing pharmacists. study team, composed licensed prior experience various healthcare settings, theory planned behavior as theoretical framework understand factors that may influence pharmacists' intentions engage patient behavior. aims incorporate perspectives multiple stakeholders, including pharmacists, regulatory bodies, law enforcement agencies, emphasize importance addressing pharmacy-specific aspects addition clinical evidence guidance. provide targeted, multidisciplinary setting.

Language: Английский

Health, harm reduction, and social service providers’ perspectives on the appropriateness and feasibility of peer distribution of HIV self-test kits among people who use drugs DOI Creative Commons
Angela R. Bazzi, Chad J. Valasek,

Tara Stamos-Buesig

et al.

Harm Reduction Journal, Journal Year: 2024, Volume and Issue: 21(1)

Published: Feb. 4, 2024

Abstract Background People who use drugs (PWUD) experience elevated HIV risk and numerous barriers to facility-based testing. self-testing (HIVST) could circumvent many of those is acceptable among PWUD, yet HIVST implementation for PWUD limited. Service providers’ perspectives on specific delivery strategies help increase availability PWUD. Methods From April–November 2021, we interviewed 16 health, harm reduction, social service providers working with in San Diego, CA. Interviews rapid thematic analysis explored HIVST’s utility appropriateness, as well the feasibility anticipated challenges strategies, including peer or secondary distribution. Results Participants viewed a significant threat health confirmed presence local promising potentially empowering solution. Based community familiarity distribution reduction supplies (i.e., naloxone) information, participants kits an appropriate feasible strategy increasing reach HIVST, but also described potential (e.g., engaging socially disconnected individuals, ensuring linkages services following HIVST) provided suggestions alternative kit models vending machines). Conclusions promising, appropriate, feasible, specialized efforts may be needed most marginalized individuals ensure consistent provision educational information referral supports that maximize impact this approach.

Language: Английский

Citations

4
Long-Acting Injectable Prep for People Who Inject Drugs at a Syringe Services Program: A Qualitative Acceptability and Feasibility Study DOI Creative Commons
Edward Suarez, Hansel Tookes,

Marissa Coppola

et al.

AIDS and Behavior, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 9, 2025

Abstract Although people who inject drugs (PWID) are at high risk of acquiring HIV, knowledge and uptake pre-exposure prophylaxis (PrEP) for HIV prevention among this population remain low due to numerous psychosocial structural barriers. Multiple implementation strategies have been proposed address gap, notably providing long-acting injectable (LAI) formulations PrEP offering syringe services programs (SSPs). This qualitative study explores the acceptability feasibility LAI-PrEP PWID Florida’s first legal SSP. In-depth semi-structured interviews were conducted with ( n = 25) healthcare providers 5), transcripts analyzed using iterative thematic analysis. The provision SSP was overwhelmingly acceptable both providers, specific advantages disadvantages compared oral elucidated. Likewise, identified facilitators barriers recommendations implementation. Overall, adds growing evidence that SSPs is feasible holds promise in expanding access PWID.

Language: Английский

Citations

0
Considerations for equitable distribution of digital healthcare for people who use drugs DOI Creative Commons
Zoi Papalamprakopoulou, Sotirios Roussos,

Elisavet Ntagianta

et al.

BMC Health Services Research, Journal Year: 2025, Volume and Issue: 25(1)

Published: April 10, 2025

Language: Английский

Citations

0
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services DOI Creative Commons
Tyler S. Bartholomew, Marina Plesons, David P. Serota

et al.

Addiction Science & Clinical Practice, Journal Year: 2024, Volume and Issue: 19(1)

Published: March 25, 2024

Abstract Background People who inject drugs (PWID) remain a high priority population under the federal Ending HIV Epidemic initiative with 11% of new infections attributable to injection drug use. There is critical need for innovative, efficacious, scalable, and community-driven models healthcare in non-stigmatizing settings PWID. We seek test Comprehensive-TeleHarm Reduction (C-THR) intervention prevention services delivered via syringe program (SSP). Methods The CHARIOT trial hybrid type I effectiveness-implementation study using parallel two-arm randomized controlled design. Participants (i.e., PWID; n = 350) will be recruited from (SSP) Miami, Florida. receive either C-THR or non-SSP clinic referral patient navigation. objectives are: (1) determine if increases engagement pre-exposure prophylaxis; PrEP medications opioid use disorder; MOUD) compared navigation, (2) examine long-term effectiveness cost-effectiveness intervention, (3) assess barriers facilitators implementation sustainment intervention. co-primary outcomes are MOUD across follow-up at 3, 6, 9 12 months. For PrEP, confirmed by tenofovir on dried blood spot cabotegravir within previous 8 weeks. MOUD, defined as screening positive norbuprenorphine methadone urine screen; naltrexone buprenorphine 4 Secondary include adherence, HCV treatment sustained virologic response, sexually transmitted infections. short long term analyses mixed-methods evaluation provide compelling data sustainability possible impact comprehensive SSPs. Discussion first our knowledge efficacy an peer-led telehealth PWID risk SSP. This innovative model seeks transform way access care bypassing traditional system, reducing multi-level care, meeting where they are. Trial Registration : ClinicalTrials.gov NCT05897099. registry name: Comprehensive Harm Prevention Via Telehealth (CHARIOT). date: 06/12/2023.

Language: Английский

Citations

3
Internet-based, continuously available Narcotics Anonymous meetings: a new resource for access to Twelve Step support for abstinence DOI Creative Commons
Marc Galanter, William L. White, Brooke D. Hunter

et al.

The American Journal of Drug and Alcohol Abuse, Journal Year: 2024, Volume and Issue: 50(3), P. 321 - 327

Published: April 1, 2024

Background: A Zoom-based website was developed in 2020 that offers continuous access to online Narcotics Anonymous (NA) meetings for the first time. This provides immediate persons with substance use disorder support abstinence from substance-related addictive disorders.

Language: Английский

Citations

2
Frame Shift: Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections DOI Open Access
Kinna Thakarar, Ayesha Appa, Jacinda C. Abdul‐Mutakabbir

et al.

Clinical Infectious Diseases, Journal Year: 2023, Volume and Issue: 78(2), P. e12 - e26

Published: Nov. 29, 2023

oppression [23

Language: Английский

Citations

4
Assessing Covid-19 Pandemic Impacts on the Health of Pwid Using a Novel Data Sharing Model DOI
Heather Bradley, Nicole Luisi,

Anastasia Carter

et al.

Published: Jan. 1, 2024

Language: Английский

Citations

1
Considerations for Equitable Distribution of Digital Healthcare for People Who Use Drugs DOI Creative Commons
Zoi Papalamprakopoulou, Sotirios Roussos,

Elisavet Ntagianta

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 20, 2024

Abstract Background Telehealth holds the potential to expand healthcare access for people who use drugs (PWUD). However, approaches increase PWUDs’ digital are not well-understood. We studied accessibility among PWUD. Methods employed respondent-driven sampling recruit 162 PWUD in Athens, Greece collect data via a structured questionnaire. Participants were aged at least 18 years and had an injection drug (IDU) history. assessed current internet computer access, experience with telemedicine. utilized logistic regression evaluate sociodemographic associations. Results Participants’ mean (standard deviation) age was 45.9 (8.8) years, 84.0% male, 90.1% Greek, 77.8% reported IDU within past year, 85.2% linked opioid treatment, 50.0% currently experiencing homelessness. Only 1.9% 46.3% familiarity Internet by 66.0% 31.5% of participants, respectively. Compared participants secure housing, those homelessness decreased (50.6% vs 81.5%, p<0.001) (11.1% 51.9%, p<0.001). Multivariable analyses revealed that older (per 1-year increase: odds ratio [OR]=0.94, 95% confidence interval [CI] [0.89, 0.99], p=0.03), year (0.29 [0.10, 0.88], (0.29, [0.13, 0.65], p=0.003) associated lower access. Homelessness (0.17, [0.07, 0.41], Conclusions infrastructure challenges, homelessness, literacy gaps should be considered bridge divide ensure equitable distribution Clintrials.gov registration number: NCT05794984

Language: Английский

Citations

1
Syringe service program-based telemedicine linkage to opioid use disorder treatment: the randomized mixed method STAMINA trial DOI Creative Commons
Dennis P. Watson,

Dana Franceschini,

James A. Swartz

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 14, 2024

Abstract Background The opioid overdose crisis necessitates expanded access to medications for use disorder (MOUD). Treatment programs often struggle engage individuals at the highest risk. This study, STAMINA, aimed participants a syringe service program (SSP) and connect them treatment through telemedicine platform. Methods In pragmatic mixed methods trial, were randomized either (n = 138) or standard referral 136). Baseline 90-day structured interviews, urine testing, administrative data from MOUD providers collected. Additionally, subset of 36) completed semi-structured qualitative interviews. study took place two SSP sites in Chicago, IL, involving 274 (78% male, 61% African American, 78% non-Latino, mean age 48) interested starting treatment. Interventions included an immediate appointment with transportation first in-person versus referral. Participants could choose methadone, buprenorphine, extended-release naltrexone. Results primary outcome was measured by attendance appointment, indicating successful linkage. Secondary outcomes engagement, retention, non-MOUD use, assessed self-report urinalysis. key determinant linkage success scheduling within 48 hours enrollment (aOR 3.20, p < .01). Methadone posed significant requirements but showed greater compared buprenorphine. reported various reasons continued illicit use. Conclusions Telemedicine alone is insufficient overcome barriers. Differences should inform design interventions. Additional supports may be necessary enhance flexible treatments like Trial registration ClinicalTrials.gov (NCT04575324).

Language: Английский

Citations

1
Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review DOI Creative Commons
Joseph Tay Wee Teck, Jenna L. Butner, Alex Baldacchino

et al.

Journal of Telemedicine and Telecare, Journal Year: 2023, Volume and Issue: unknown

Published: Sept. 4, 2023

The COVID-19 pandemic has instigated the development of telemedicine-mediated provision medications for opioid use disorder such as buprenorphine and methadone, referred to TMOUD in this study. As services start return pre-pandemic norms, there is a debate around role addition or replacement conventional cascade care people with (PWOUD). This scoping review designed characterize existing provide insights enable more nuanced discussion on telemedicine PWOUD.The literature search was conducted OVID Medline, CINAHL, PsycINFO, from inception up including April 2023, using Joanna Briggs Institute methodology reviews. considered any study design that detailed sufficient descriptive information given service. A data extraction form developed collect categorize range characteristics each discrete model identified obtained articles.A total 45 articles met inclusion criteria, this, 40 were identified. In total, 33 US-based, three Canada, one India, Ireland, UK, Norway. Through analysis service characteristics, four models These facilitate health, transitions care, meet complex healthcare needs, maintain (OUD) resilience.Characterizing according its functional benefits PWOUD OUD will help support evidence-based policy practice. Additionally, particular attention how digital exclusion can be mitigated against.

Language: Английский

Citations

3